» Articles » PMID: 2766903

Absence of Effect of 16,16-dimethyl Prostaglandin E2 on Reduction of Gastric Mucosal Blood Flow Caused by Indomethacin in Rats

Overview
Journal Dig Dis Sci
Specialty Gastroenterology
Date 1989 Sep 1
PMID 2766903
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The effects of 16,16-dimethyl prostaglandin E2 PGE2 on gastric mucosal blood flow and gastric mucosal damage were tested in rats given indomethacin. Blood flow was measured by hydrogen gas clearance. Indomethacin given intragastrically reduced the blood flow in nonlesion areas and the levels of PGE2 and 6-keto-PGF1 alpha in the gastric mucosa and caused mucosal damage in a dose-related way. Indomethacin (20 mg/kg) significantly reduced the blood flow 30 min after administration, and the reduction increased until 90 min. Then the flow plateaued until 240 min. Gastric mucosal damage caused by 20 mg/kg of indomethacin and evaluated by only gross observations, began at 60 min and developed with time until 240 min after administration. 16,16-Dimethyl PGE2 (5 micrograms/kg) did not affect the reduction of blood flow caused by indomethacin during 240 min of measurements, but it significantly inhibited the indomethacin-induced mucosal damage evaluated by gross observations. These results suggest that prevention by 16,16-dimethyl PGE2 of grossly observed gastric mucosal damage caused by indomethacin was not related by preservation of the gastric mucosal blood flow in the areas without lesions.

Citing Articles

Rebamipide, a mucoprotective drug, inhibits NSAIDs-induced gastric mucosal injury: possible involvement of the downregulation of 15-hydroxyprostaglandin dehydrogenase.

Tanigawa T, Watanabe T, Ohkawa F, Nadatani Y, Otani K, Machida H J Clin Biochem Nutr. 2011; 48(2):149-53.

PMID: 21373268 PMC: 3045688. DOI: 10.3164/jcbn.10-75.


Effect of diet on changes in small intestinal blood flow following intracolonic administration of indomethacin to rats.

Yamamoto C, Kawakubo K, Aoyagi K, Matsumoto T, Iida M, Ibayashi S Dig Dis Sci. 2001; 46(1):200-7.

PMID: 11270787 DOI: 10.1023/a:1005529016641.


Bosentan, a novel synthetic mixed-type endothelin receptor antagonist, attenuates acute gastric mucosal lesions induced by indomethacin and HCl in the rat: role of endogenous endothelin-1.

Matsumaru K, Kashimura H, Hassan M, Nakahara A, Hayashi T, Iwata R J Gastroenterol. 1997; 32(2):164-70.

PMID: 9085162 DOI: 10.1007/BF02936362.


Helicobacter pylori and non-steroidal anti-inflammatory drugs: uncomfortable partners in peptic ulcer disease.

Taha A, Russell R Gut. 1993; 34(5):580-3.

PMID: 8504954 PMC: 1374170. DOI: 10.1136/gut.34.5.580.


Inability of cytoprotection to occur during a period of gastric ischemia.

Frydman G, Penney A, Malcontenti C, OBrien P Dig Dis Sci. 1991; 36(10):1353-60.

PMID: 1914755 DOI: 10.1007/BF01296799.

References
1.
McGreevy J, Moody F . Protection of gastric mucosa against aspirin-induced erosions by enhanced blood flow. Surg Forum. 1977; 28:357-9. View

2.
Gerber J, Nies A . Canine gastric mucosal vasodilation with prostaglandins and histamine analogs. Dig Dis Sci. 1982; 27(10):870-4. DOI: 10.1007/BF01316568. View

3.
Miller T, Henagan J, Robert A . Effect of 16, 16-dimethyl PGE2 on resting and histamine-stimulated gastric mucosal blood flow. Dig Dis Sci. 1980; 25(8):561-7. DOI: 10.1007/BF01318867. View

4.
Robert A, NEZAMIS J, Lancaster C, Hanchar A . Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology. 1979; 77(3):433-43. View

5.
Konturek S, Robert A . Cytoprotection of canine gastric mucosa by prostacyclin: possible mediation by increased mucosal blood flow. Digestion. 1982; 25(3):155-63. DOI: 10.1159/000198824. View